| Stage | MAN | % of rev | RHI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.8B | 100.00% | $1.4B | 100.00% | MAN ×3.56 |
| Gross profit | $767M | 15.85% | $532M | 39.14% | RHI +23.3pp |
| Operating income | $82M | 1.70% | $73M | 5.34% | RHI +3.6pp |
| Pre-tax income | $68M | 1.40% | $75M | 5.49% | RHI +4.1pp |
| Net income | $34M | 0.70% | $50M | 3.67% | RHI +3.0pp |
| Stage | MAN | RHI | Gap · A − B |
|---|---|---|---|
| Revenue | $4.8B100.00% | $1.4B100.00% | MAN ×3.56 |
| Gross profit | 15.85%$767M | 39.14%$532M | RHI +23.3pp |
| Operating income | 1.70%$82M | 5.34%$73M | RHI +3.6pp |
| Pre-tax income | 1.40%$68M | 5.49%$75M | RHI +4.1pp |
| Net income |
None
No disclosed counterparties: MAN.
| 0.70%$34M |
| 3.67%$50M |
| RHI +3.0pp |